On June 22, 2023, Theraclion SA closed the transaction. the company issued 14,478,269 ABSAs, new shares with warrants attached, each with a par value of of â¬0.577 for the gross proceeds of of â¬8,353,961.213 along with additional warrants of of â¬1,300,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.375 EUR | +4.17% | +4.17% | -3.35% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.35% | 17.42M | |
+8.69% | 219B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 108B | |
+0.27% | 63.06B | |
+12.72% | 52.02B | |
+3.96% | 48.2B | |
+0.40% | 40.37B | |
+15.03% | 39.35B |
- Stock Market
- Equities
- ALTHE Stock
- News Theraclion
- Theraclion SA announced that it has received €8.353961 million in funding from Furui Medical Science Company Luxembourg S.à r.l.